Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission

Digital Asset Direct by Oxford Cannabinoid Technologies Holdings PLC

London, UK | January 06, 2023 04:58 AM Eastern Standard Time

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) chief scientific officer Dr Valentino Parravicini speaks to Proactive after submitting a phase 1 trial application for its lead programme (OCT461201) to the UK Medicines & Healthcare products Regulatory Agency (MHRA) and Wales Research Ethics Committee (REC). Parravicini says that the submission demonstrates that the company is "ready to go" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com